Billing and Coding: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer

Claims for Non-Next Generation Sequencing targeted molecular panel tests for predictive cancer testing must report the appropriate CPT and ICD-10-CM codes, include the DEX Z-Code identifier adjacent to the CPT code in specified comment/narrative fields for Part A and Part B claims, and use one unit of service per claim line. Do not add extra characters to the SV101-7 field when entering the DEX Z-Code, and follow the referenced LCD (DL40226) and MolDX article (A57910) for supplemental billing and coding guidance.

"Do not add any additional characters or information when entering the DEX Z-Code on the SV101-7 field for Part B claims."

Sign up to see full coverage criteria, indications, and limitations.